拓展放疗治疗窗:分子靶向治疗与纳米材料视角
本文综述了增强放疗疗效并降低毒性的临床策略,以拓展放疗治疗窗。重点讨论了已鉴定的分子靶点及其增强放疗的作用机制,包括EGFR、PI3K/AKT/mTOR通路、DNA修复基因PARP与ATM/ATR、血管生成生长因子、表观遗传调控因子及免疫检查点蛋白;并综述了纳米颗粒递送化疗药、金属(高Z)纳米颗粒及纳米颗粒递送靶向治疗等增强放疗的策略。
要点
- 靶向EGFR、PI3K/AKT/mTOR、PARP、ATM/ATR等通路可干预肿瘤对电离辐射的抵抗。
- 纳米颗粒递送化疗药、高Z金属纳米颗粒及递送靶向药有望增强肿瘤对电离辐射的应答或降低正常组织毒性。
- 局部晚期肺、头颈及消化道肿瘤因局部和区域复发风险高,是新型放射增敏剂的重点需求人群。
核心结论
- 通过操控肿瘤对电离辐射的多种抵抗机制,靶向治疗对拓展放疗治疗窗具有重要价值。
- 纳米颗粒递送化疗药、金属(高Z)纳米颗粒及纳米颗粒递送靶向治疗均可能通过增强肿瘤对电离辐射的应答或降低正常组织毒性来改善放疗治疗窗。
研究设计与样本
- 本文为综述,讨论增强放疗疗效、降低毒性从而拓展整体治疗窗的临床策略;检索范围未在摘要中报告。
主要发现
- 已鉴定的分子靶点包括细胞存活与增殖信号通路如EGFR和PI3K/AKT/mTOR、DNA修复基因包括PARP和ATM/ATR、血管生成生长因子、表观遗传调控因子及免疫检查点蛋白。
- 超过半数癌症患者在治疗过程中接受放疗,放疗与手术、化疗和免疫治疗并列为现代肿瘤治疗的基石。
- 局部晚期肺、头颈和消化道肿瘤局部及区域复发风险升高,是新型放射增敏剂的重点需求方向。
临床怎么用
- 可关注针对EGFR、PI3K/AKT/mTOR、PARP、ATM/ATR等靶点的放射增敏策略及其与放疗联合的潜在治疗窗获益。
- 纳米颗粒递送化疗药、高Z金属纳米颗粒及纳米颗粒递送靶向治疗是增强放疗应答或降低正常组织毒性的可行研究方向。
局限性
- 本文为综述性视角文章,摘要未报告具体研究设计、样本量或定量疗效数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Radiation therapy is a cornerstone of modern cancer therapy alongside surgery, chemotherapy, and immunotherapy, with over half of all cancer patients receiving radiation therapy as part of their treatment regimen. Development of novel radiation sensitizers that can improve the therapeutic window of radiation therapy are sought after, particularly for tumors at an elevated risk of local and regional recurrence such as locally-advanced lung, head and neck, and gastrointestinal tumors. This review discusses clinical strategies to enhance radiotherapy efficacy and decrease toxicity, hence, increasing the overall therapeutic window. A focus is given to the molecular targets that have been identified and their associated mechanisms of action in enhancing radiotherapy. Examples include cell survival and proliferation signaling such as the EGFR and PI3K/AKT/mTOR pathways, DNA repair genes including PARP and ATM/ATR, angiogenic growth factors, epigenetic regulators, and immune checkpoint proteins. By manipulating various mechanisms of tumor resistance to ionizing radiation (IR), targeted therapies hold significant value to increase the therapeutic window of radiotherapy. Further, the use of novel nanoparticles to enhance radiotherapy is also reviewed, including nanoparticle delivery of chemotherapies, metallic (high-Z) nanoparticles, and nanoparticle delivery of targeted therapies - all of which may improve the therapeutic window of radiotherapy by enhancing the tumor response to IR or reducing normal tissue toxicity.
引用
- Reda M, Bagley AF, Zaidan HY, et al. Augmenting the therapeutic window of radiotherapy: A perspective on molecularly targeted therapies and nanomaterials. Radiother Oncol. 2020. PMID: 32598976. doi:10.1016/j.radonc.2020.06.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。